Here is a thorough explanation, now drawing from the textbook sources:
Why Mucosal Melanoma Has No Stage I or Stage II (AJCC/UICC System)
The Core Reason: The TNM T-category starts at T3
In the AJCC/UICC 8th Edition (2017) staging system for head and neck mucosal melanoma, the T-category classification begins at T3 - there is no T1 or T2. This is not an oversight; it reflects a deliberate biological and anatomical reality.
From Cummings Otolaryngology (Table 94.3 - Mucosal Melanoma Staging):
| T Category | Criteria |
|---|
| T3 | Tumors limited to the mucosa and immediately underlying soft tissue, regardless of thickness or greatest dimension (e.g., polypoid nasal disease, pigmented or nonpigmented lesions of the oral cavity, pharynx, or larynx) |
| T4a | Moderately advanced - tumor involving deep soft tissue, cartilage, bone, or overlying skin |
| T4b | Very advanced - tumor involving brain, dura, skull base, lower cranial nerves (IX, X, XI, XII), masticator space, carotid artery, prevertebral space, or mediastinal structures |
Because there is no T1 or T2, the resulting overall stage grouping maps as:
- T3 N0 M0 = Stage III
- T4a N0/N1 M0 = Stage IVA
- T4b Any N M0 or Any T N1 M0 = Stage IVB
- Any T Any N M1 = Stage IVC
Stages I and II simply do not exist because no T1 or T2 tumors are defined.
Why T1 and T2 Are Absent - The Key Reasons
1. Lack of histologic landmarks analogous to the dermis
Cutaneous melanoma is staged using Breslow thickness (depth of invasion in mm) because the layers of skin - epidermis, papillary dermis, reticular dermis - provide measurable, reproducible landmarks. Mucosal surfaces (oral cavity, sinonasal tract, anogenital mucosa) do not have the same layered architecture. There is no equivalent to the papillary/reticular dermis junction in mucosa, so depth-based T-staging (which underpins T1 and T2 in cutaneous melanoma) cannot be applied.
2. Tumors are almost always locally advanced at diagnosis
As noted in Dermatology 2-Volume Set 5e:
"These tumors tend to be diagnosed at a locally advanced stage with associated poor prognosis."
Mucosal sites (nasopharynx, sinonasal cavity, vulva, vagina, rectum) are anatomically hidden and symptom-poor in early disease. By the time a mucosal melanoma causes symptoms (bleeding, obstruction, mass effect), it is already invading the submucosa or deeper tissues. The concept of a thin, early, in-situ-equivalent lesion (T1 in cutaneous) is rarely if ever encountered clinically in sufficient numbers to define a meaningful prognostic group.
3. Tumor size is not a staging component
Unlike cutaneous or other solid-organ tumors, tumor size is not incorporated into the mucosal melanoma T-stage. Any tumor confined to mucosa and immediately underlying soft tissue - regardless of how large it is - is classified T3. This reflects evidence that size alone does not meaningfully stratify prognosis in this disease.
4. Uniformly poor prognosis
"Mucosal melanomas have a uniformly poor prognosis and this is reflected in the staging. There are no T1 or T2 categories and all mucosal melanomas are classified as either T3 or T4."
Because even the "earliest" detectable lesion (T3) carries a poor outlook, there is no biological justification for creating lower-risk categories (T1/T2) that do not exist in practice.
What About the Simplified 3-Stage System?
For anorectal and vaginal mucosal melanoma, a simpler 3-stage system is sometimes used (e.g., at institutions like Memorial Sloan Kettering):
| Stage | Description |
|---|
| Stage I | Clinically localized disease |
| Stage II | Regional nodal involvement |
| Stage III | Distant metastatic disease |
Note: This is a different (older, simplified) 3-stage system used for non-head-and-neck sites - it does have a Stage I and II. The question of "no Stage I/II" applies specifically to the AJCC/UICC TNM-based overall stage groupings for head and neck mucosal melanoma, where the absence of T1/T2 means Stages I and II cannot be generated.
Summary
| Reason | Explanation |
|---|
| No T1/T2 defined | Mucosal anatomy lacks dermal landmarks; depth-based early staging is not applicable |
| Late presentation | Tumors are almost always locally advanced by the time of diagnosis |
| Size irrelevant | Tumor size does not predict prognosis; even small mucosal melanomas behave aggressively |
| Uniformly poor prognosis | No biologically meaningful low-risk group exists to warrant Stages I/II |
- Cummings Otolaryngology Head and Neck Surgery, Table 94.3
- Dermatology 2-Volume Set 5e, Mucosal Melanoma section
- Melanoma Focus HNMM Guidelines